Dr. Lin Kong 孔琳
Chief Physician
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Precision radiotherapy for head, neck, and central nervous system tumors, including nasopharyngeal, oral, laryngeal, eye, brain, and rare tumors. Expertise in photon IMRT, proton and heavy ion therapy, and comprehensive treatment.
Dr. Kong holds a medical doctorate and serves as Chief Physician and doctoral supervisor. Dr. Kong is an instructor for PTCOG educational courses and a Shanghai Academic/Technical Leader. Current roles include Director of the Head, Neck, and Central Nervous System Tumor Department at the Shanghai Proton and Heavy Ion Center and Fudan University Shanghai Cancer Center.
Professional roles
- Chair, Proton and Heavy Ion Radiotherapy Committee, China Health Promotion Association
- Vice Chair, Particle Radiotherapy Committee, China Anti-Cancer Association
- Standing Committee Member, Tumor Precision Therapy Committee, China Anti-Cancer Association
- Standing Committee Member, Oral and Maxillofacial Tumor Integration Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Kong Lin). Papers usually list the name as Lin Kong or Kong L.
Selected publications
38 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- Curr Pharm Des, 2026 (senior author): Triptonide Mediates Apoptosis and Autophagy via ROS/p38 MAPK Activation and mTOR/NF-κB Inhibition in Nasopharyngeal Carcinoma: Insights from Network Pharmacology, Molecular Docking, and Experimental Validation. PubMed 41178776
- Redox Biol, 2025 (senior author): Carbon ion combined photon radiotherapy induces ferroptosis via NCOA4-mediated ferritinophagy in glioblastoma. PubMed 40925125
- J Transl Med, 2025 (senior author): Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma. PubMed 40993737
- Acta Biochim Biophys Sin (Shanghai), 2025 (senior author): Autophagy-dependent sensitization effects of PARP inhibitors on recurrent nasopharyngeal carcinoma treated with carbon ion and photon irradiation. PubMed 40891246
- Int J Mol Sci, 2025 (senior author): The Circadian Rhythm Gene Network Could Distinguish Molecular Profile and Prognosis for Glioblastoma. PubMed 40565338
- Curr Pharm Des, 2024 (senior author): Exploring the Therapeutic Potential of Triptonide in Salivary Adenoid Cystic Carcinoma: A Comprehensive Approach Involving Network Pharmacology and Experimental Validation. PubMed 38910414
- Front Oncol, 2020 (senior author): Intensity-Modulated Radiation Therapy for Esthesioneuroblastoma: 10-Year Experience of a Single Institute. PubMed 32766154
- Cancer, 2020 (first author): Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center. PubMed 32167589
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion